SCHEMBL9007738

SCHEMBL9007738

NC(=O)C(N)CCC[C@@H](N)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.60
NOS2 P35228 8/20 0.57
CYP1A2 P05177 3/20 0.57
CYP2C19 P33261 2/20 0.57
TSHR P16473 2/20 0.57
GLA P06280 1/20 0.57
NFKB1 P19838 1/20 0.57
APEX1 P27695 1/20 0.57
KMT2A Q03164 2/20 0.56
BLM P54132 2/20 0.56
ALOX15 P16050 1/20 0.56
PMP22 Q01453 1/20 0.56
ARG2 P78540 4/20 0.54
ARG1 P05089 3/20 0.54
NOS1 P29475 6/20 0.53
NOS3 P29474 4/20 0.53
MEN1 O00255 1/20 0.53
GRM8 O00222 1/20 0.52
GRM6 O15303 1/20 0.52
GRIN2D O15399 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9007740 1.00 GSR (0.60) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL3954319 1.00 GSR (0.60) GSRNOS2CYP1A2CYP2C19TSHR
Hydrochloric Acid SCHEMBL10420618 0.98 GSR (0.58) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL15778941 0.90 KMT2A (0.61) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL15778940 0.90 KMT2A (0.61) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL15778942 0.90 KMT2A (0.61) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL29289 0.89 GSR (0.71) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL10135848 0.89 GSR (0.71) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL29387596 0.89 GSR (0.71) GSRNOS2CYP1A2CYP2C19TSHR
SCHEMBL29291 0.89 GSR (0.71) GSRNOS2CYP1A2CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593491-B1 LUTEINIZING HORMONE RELEASING HORMONE ANTAGONIST PEPTIDES DEGHENGHI ROMANO (CH) 1996-10-23 EP claimed